A UK government panel on coronavirus vaccinations has said people under the age of 30 should be offered an alternative to the AstraZeneca vaccine.
The move has come in the wake of concerns regarding vaccine's link to blood clots. 19 people have died in the UK from rare blood clots after receiving the jab. Altogether, 79 such cases have been reported in the country.
The committee's advice came hours after the European Union's drug regulator said it had found a "possible link" between the AstraZeneca vaccine and the clotting disorder.
But the agency did not recommend any new restrictions, saying the benefits of the shot still outweigh risks.